NMDA-R inhibition affects cellular process formation in Tilapia Melanocytes; a model for pigmented adrenergic neurons in process formation and retraction
- 216 Downloads
Parkinson’s disease has long been described to be a product of dopamine and (or) melanin loss in the substanstia nigra (SN). Although most studies have focused on dopaminergic neurons, it is important to consider the role of pigment cells in the etiology of the disease and to create an in vitro live cell model for studies involving pigmented adrenergic cells of the SN in Parkinsonism. The Melanocytes share specific features with the pigmented adrenergic neurons as both cells are pigmented, contain adrenergic receptors and have cellular processes. Although the melanocyte cellular processes are relatively short and observable only when stimulated appropriately by epinephrine and other factors or molecules. This study employs the manipulation of N-Methyl-D-Aspartate Receptor (NMDA-R), a major receptor in neuronal development, in the process formation pattern of the melanocyte in order to create a suitable model to depict cellular process elongation and shortening in pigmented adrenergic cells. NMDA-R is an important glutamate receptor implicated in neurogenesis, neuronal migration, maturation and cell death, thus we investigated the role of NMDA-R potentiation by glutamate/KCN and its inhibition by ketamine in the behavior of fish scale melanocytes in vitro. This is aimed at establishing the regulatory role of NMDA-R in this cell type (melanocytes isolated form Tilapia) in a similar manner to what is observable in the mammalian neurons. In vitro live cell culture was prepared in modified Ringer’s solution following which the cells were treated as follows; Control, Glutamate, Ketamine, Glutamate + Ketamine, KCN + Ketamine and KCN. The culture was maintained for 10 min and the changes were captured in 3D-Time frame at 0, 5 and 10 min for the control and 5, 7 and 10 min for each of the treatment category. Glutamate treatment caused formation of short cellular processes localized directly on the cell body while ketamine treatment (inhibition of NMDA-R) facilitated elongation of secondary cellular processes (highly branched) from primary major processes (Less branched); co-incubation of glutamate and ketamine induced short and highly branched process formation. Cyanide toxicity induced degeneration and reduction of cell size while co-treatment of cyanide and ketamine gave changes similar to that observed in glutamate-ketamine co-incubation. NMDA-R is present in the melanocytes. Activation of the receptor reduced elongation process, while inhibition of the receptor facilitated cell process elongation and branching. This confirms that like pigmented adrenergic cells of the nervous system, this cell contains NMDA-R and this receptor also regulates cell process elongation. The study also showed that inhibition of NMDA-R in melanocytes gave opposite outcomes to the role of the receptor in developing neurons; a function that is protective in adult neurons.
KeywordsNMDA-R Glutamate Melanocytes Neurons Parkinson’s disease and Cell Models
We acknowledge the resources shared and provided by the Alzheimer’s Drug Discovery Foundation (ADDF). The Directorate of Research, Afe Babalola University and the Laboratory Staffs of the Department of Biological Sciences. Also we acknowledge the contributions of Elizabeth Peters of the College of Medicine for assisting in the revision of this work.
Conflict of Interest (COI) Statement
The Authors hereby declare there is no conflict of interest associated with this study or any of the procedures and materials used for the purpose of the study.
- Benkler M, Agmon-Levin N, Hassin-Baer S, Cohen OS, Ortega-Hernandez OD, Levy A, Moscavitch SD, Szyper-Kravitz M, Damianovich M, Blank M, Chapman J, Shoenfeld Y (2012) Immunology, autoimmunity, and autoantibodies in Parkinson's disease. Clin Rev Allergy Immunol 42(2):164–171. doi: 10.1007/s12016-010-8242-y PubMedCrossRefGoogle Scholar
- Bohlega SA, Al-Foghom NB (2013) Drug-induced Parkinson`s disease. A clinical review. Neurosciences (Riyadh) 18(3):215–221Google Scholar
- Han Z, Yang JL, Jiang SX, Hou ST, Zheng RY (Fast non-competitive and reversible inhibition of NMDA activated current by 2-BFI confers Neuroprotection) Fast non-competitive and reversible inhibition of NMDA activated current by 2-BFI confers Neuroprotection. PLos One 8(5):e64894Google Scholar
- Himmelseher, S and Kochs E (2004). Neuroprotection by ketamine. Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E. 2004, pp 893–901Google Scholar
- Holmes S, Abbassi B, Su C, Singh M and Cunningham R.L (2013). Oxidative stress determines neuroprotective and neurotoxic properties of androgens in immortalized female rats dopaminergic neuronal cells. Endocrinology. August 19 [Epub Ahead of Print].Google Scholar
- Jablonka S, Dombert B, Asan E and Sendtner M (2013). Mechanism of axon maintenance and plasticity in motor neurons. Journal of Anatomy, Sept. 6 [Epub Ahead of Print].Google Scholar
- Karlsson O, Lindquist NG (2013). Melanin affinity and its possible role in neurodegeneration. J Neural Transm. 2013 Jul 3. [Epub ahead of print]Google Scholar
- Lie OV, Bennett GD, Rosenquist TH (2010) The N-Methyl-D-Aspartate Receptor in heart development: a gene knockdown model using siRNA. Reprod Toxicol 29(1):32Google Scholar
- Maskos U, McKay RD (2003) Neural cells without functional N-Methyl-D-Aspartate (NMDA) Receptors contribute extensively to normal postnatal brain development in efficiently generated chimaeric NMDA R -/-<- ->+/+ mice. Developmental Biology 262(1):119–136Google Scholar
- Menna E, Zambetti S, Morini R, Donzelli A, Disanza A, Calvigioni D, Braida D, Nicolini C, Orlando M, Fossati G, Cristina Regondi M, Pattini L, Frassoni C, Francolini M, Scita G, Sala M, Fahnestock M, Matteoli M (2013) Eps8 controls dendritic spine density and synaptic plasticity through its actin-capping activity. EMBO J 32(12):1730–1744. doi: 10.1038/emboj.2013.107 PubMedCrossRefGoogle Scholar
- Ogundele O.M, Olaniyan T.O, Dare B.J, Omotoso D.R, Omotosho O.D, Akintayo O.C, Memudu A.E and Caxton-Martins E.A (2012). Neuroprotective Properties of NMDA R Antagonist (Ketamine) in Cyanide Treated Neurons in vitro. Annual Review & Research in Biology, ISSN: 2231–4776,Vol.: 2, Issue.: 3 (July-September)Google Scholar
- Pachoud B, Adamantidis A, Ravassard P, Luppi PH, Grisar T, Lakaye B, Salin PA (2010) Major impairments of glutamatergic transmission and long-term synaptic plasticity in the hippocampus of mice lacking the melanin-concentrating hormone receptor-1. J Neurophysiol 104(3):1417–1425. doi: 10.1152/jn.01052.2009, Epub 2010 Jun 30PubMedCrossRefGoogle Scholar
- Payer DE, Behzadi A, Kish SJ, Houle S, Wilson AA, Rusjan PM, Tong J, Selby P, George TP, McCluskey T, Boileau I (2013) Heightened D3 Dopamine Receptor Levels in Cocaine Dependence and Contributions to the Addiction Behavioural Phenotype: A Positron Emission Tomography Study with [11C]-(+)-PHNO. Neuropsychopharmacology. doi: 10.1038/npp.2013.192 [Epub ahead of print]PubMedGoogle Scholar
- Saraswat RC, Ram N (1972) Quantification of Amino Acids in Fish scale. Indian J Fishery; 17:21–25Google Scholar
- Thobois S, Lhommée E, Klinger H, Ardouin C, Schmitt E, Bichon A, Kistner A, Castrioto A, Xie J, Fraix V, Pelissier P, Chabardes S, Mertens P, Quesada JL, Bosson JL, Pollak P, Broussolle E, Krack P (2013) Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain 136(Pt 5):1568–1577PubMedCrossRefGoogle Scholar
- Zhu Y (2013). The Drosophila visual system: From neural circuits to behavior. Cell Adh Migr. 2013 Jun 27;7(4). [Epub ahead of print].Google Scholar